Tumor Hospital of Xinjiang Medical University

Recent papers from Tumor Hospital of Xinjiang Medical University

1. Integrative Genetic and Functional Analysis Identifies the Asparagine–SLC38A2 Axis in Esophageal Squamous Cell CarcinomaMolecular Carcinogenesis · 2026
2. A Qualitative Study of Preventive Behaviors Among Patients Considered at High Risk of Lower Limb Lymphedema After Gynecological Cancer Surgery Using the Theoretical Domains FrameworkPatient Preference and Adherence · 2026
3. EP300 promotes macrophage M2 polarization in diffuse large B-cell lymphoma through the NF-κB/CXCR4 axis2026
4. Comprehensive pan-cancer characterization of PTPN3 reveals its prognostic, immunological, and tumorigenic significance across human malignanciesDiscover Oncology · 2026
5. Noninvasive Detection and Subtyping of Esophageal Cancer by Circulating Cell‐Free mtDNA Fragmentomics: A Multi‐Center Validation StudyAdvanced Science · 2026
6. Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 TrialJournal of Clinical Oncology · 2026
7. MGAT3 suppresses malignant phenotypes and attenuates EGFR/AKT/ERK signaling in lung adenocarcinoma cells in association with bisecting GlcNAc remodelingDiscover Oncology · 2026
8. Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1–Negative Advanced NSCLCNew England Journal of Medicine · 2026
9. Association of HSD3B1 rs1047303 polymorphism with prognosis in metastatic prostate cancer: A systematic review and meta-analysisBiochemistry and Biophysics Reports · 2026
10. ACSS2 phosphorylation at Ser659 attenuates neuronal apoptosis induced by cerebral ischemia-reperfusion by initiating autophagyScientific Reports · 2026
11. Early identification of axillary lymph node metastasis in patients with primary breast cancer based on 3D deep learning radiomics nomogramCurrent Radiopharmaceuticals · 2026
12. Anbenitamab plus HB1801 for HER2-Positive Advanced Breast CancerNew England Journal of Medicine · 2026
13. Efficacy and Safety of Benmelstobart Plus Anlotinib in Advanced Endometrial Cancer: Results of a Multi‐Cohort, Phase II Study (ETER200)MedComm · 2026
14. Proteomic Landscape and Clinical Implications of Ovarian CarcinosarcomaThe FASEB Journal · 2026
15. Cross database bibliometric and knowledge mapping analysis of nanoplatform mediated tumor associated macrophage reprogrammingDiscover Nano · 2026
16. Diagnostic value of plasma TFF3‐centered combined biomarker panel in early gastrointestinal cancerView · 2026
17. circ-RHOT1 Knockdown Suppresses Malignant Phenotypes and Reduces Stemness-Associated Marker Expression in Triple-Negative Breast Cancer Cells through PRMT5Journal of Mammary Gland Biology and Neoplasia · 2026
18. Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K /Akt/ mTOR Pathway in Triple‐Negative Breast CancerClinical and Experimental Pharmacology and Physiology · 2026
19. Assessment of Factors and Trends Affecting Different Pathological Types of Cervical Cancer in China From 2013 to 2022Cancer Medicine · 2026
20. The translational chasm in machine learning for triple-negative breast cancer: a quantitative landscape assessmentFrontiers in Oncology · 2026